Showing 1 - 6 results of 6 for search 'Johan Bussink', query time: 0.03s
Refine Results
-
1
-
2
-
3
-
4
Stereotactic radiotherapy boost after definite chemoradiation for non-responding locally advanced NSCLC based on early response monitoring 18F-FDG-PET/CT by Tineke W.H. Meijer, Robin Wijsman, Edwin A. Usmanij, Olga C.J. Schuurbiers, Peter van Kollenburg, Liza Bouwmans, Johan Bussink, Lioe-Fee de Geus-Oei
Published 2018-07-01
Article -
5
The Influence of the Exclusion of Central Necrosis on [<sup>18</sup>F]FDG PET Radiomic Analysis by Wyanne A. Noortman, Dennis Vriens, Charlotte D. Y. Mooij, Cornelis H. Slump, Erik H. Aarntzen, Anouk van Berkel, Henri J. L. M. Timmers, Johan Bussink, Tineke W. H. Meijer, Lioe-Fee de Geus-Oei, Floris H. P. van Velden
Published 2021-07-01
Article -
6
Stereotactic ablative body radiotherapy (SABR) combined with immunotherapy (L19-IL2) versus standard of care in stage IV NSCLC patients, ImmunoSABR: a multicentre, randomised contr... by Relinde I. Y. Lieverse, Evert J. Van Limbergen, Cary J. G. Oberije, Esther G. C. Troost, Sine R. Hadrup, Anne-Marie C. Dingemans, Lizza E. L. Hendriks, Franziska Eckert, Crispin Hiley, Christophe Dooms, Yolande Lievens, Monique C. de Jong, Johan Bussink, Xavier Geets, Vincenzo Valentini, Giuliano Elia, Dario Neri, Charlotte Billiet, Amir Abdollahi, David Pasquier, Pierre Boisselier, Ala Yaromina, Dirk De Ruysscher, Ludwig J. Dubois, Philippe Lambin
Published 2020-06-01
Article